Sustainable innovation for the benefit of honey bees, beekeeping and people!
Developing new solutions to address the various challenges in the beekeeping industry is a key focus of our Véto-pharma strategy and has been one of our commitments for more than 25 years.
To effectively address these issues, Véto-pharma devotes between 8 and 10% of its resources each year to innovation.
In 2021, the beekeeping innovation team relocated its research centre to EVA (Honey Bee Centre, or Espace de Valorisation de l’Abeille), an area dedicated to promoting honey bees set up by Véto-pharma in Chaillac, in central France, with the aim of stepping up its research into new active substances to fight varroa. This establishment that has worked to support and promote bees and beekeeping since it opened in 2015 houses the technical and operational centre of its testing apiary.
A fast-moving environment born of new challenges. Véto-pharma is a laboratory dedicated to the health of the honey bee, an insect that is vital for biodiversity. As such, we focus our research and development on an innovative range of safe, high-added-value products and services, meeting both quality requirements and environmental concerns.
EVA – (Espace de Valorisation de l’Abeille) The Honey Bee Centre welcomes the innovation team and its research laboratory attached to the Véto-pharma testing apiary.
Table of Contents Varroa mites are one of the major threats leading to bee colony losses at a global level. Véto-pharma will support Simon Fraser University (SFU) in the development and registration of a new miticide based on the innovative compound recently discovered and patented by SFU. Honey bees, guardians of our biodiversity, are… Continue reading New treatment against Varroa mites: Véto-pharma and Simon Fraser University join forces
EVA–Véto-pharma becomes the company’s reference R&D centre and now hosts its anti-Varroa mite research team
The Véto-pharma R&D team will now occupy part of EVA in order to intensify its search for new active substances to combat major bee predators, including Varroa mites.
Véto-pharma’s innovation team has tested 38 new active ingredients to combat varroa using its unique molecule screening method, in order to identify which molecules might be used to develop the varroa treatments of the future.